Countdown Begins for WCIT|IDECS 2023: Unlocking the Potential of the Innovative Tech Industry and Digital Economy
KUCHING, MALAYSIA, Aug 15, 2023 – (ACN Newswire) – The 50-day countdown has begun for…
KUCHING, MALAYSIA, Aug 15, 2023 – (ACN Newswire) – The 50-day countdown has begun for…
Companies integrate market-leading XDR and SASE capabilities to protect remote employees and access to critical…
PORTLAND, Ore.–(BUSINESS WIRE)–Global energy storage platform provider Powin LLC (Powin) today welcomes Jeff Waters to…
Turing will deliver AI and IoT solutions across water and wastewater treatment and distribution systems….
Census Collaborates with Databricks to Help Mutual Customers Activate First-Party Data from the Data Lakehouse…
Confirmed historic space-based 4G LTE cellular broadband capabilities alongside AT&T, Vodafone and Nokia; and completed…
Combats aggressive layer 7 DDoS attacks without disrupting legitimate traffic TEL AVIV, Israel, Aug. 15,…
Announced pricing of approximately $5 million equity financing (approximately $5.7 million if underwriter’s overallotment option…
FORT WORTH, Texas, Aug. 15, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (the…
Press Release no. 03/2023 cBrain announces AI for Government Initiative Copenhagen, August 14, 2023 cBrain…
New York, New York–(Newsfile Corp. – August 15, 2023) – BeeSeen Solutions announces target lead…
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future,” “FF,” or “Company”), a…
Company Delivers Top-Line Revenue Growth and Improvements in Profitability and Key Operating Metrics Announces Strategic…
Net Income improved over $500,000, EPS of $0.03 vs. $(0.09) COLUMBUS, Ohio–(BUSINESS WIRE)–Intellinetics, Inc. (NYSE…
Transphorm Reports First Quarter Revenue of $5.9 Million, Representing 14% Year-Over-Year Growth Fiscal First Quarter…
ColoAlert® Revenue Increases 108% Year Over Year in the First Six Months of 2023 ColoFuture…
REDWOOD CITY, Calif. & DUBLIN–(BUSINESS WIRE)–MariaDB plc (NYSE: MRDB) today announced its financial results for…
Mylight study met its primary efficacy endpoint and showed no clinically meaningful differences to reference…
Increase in Cresemba® and Zevtera® related revenue to CHF 80.5 million (+57% year-on-year) Increase in…
Ad hoc announcement pursuant to Art. 53 LR ALLSCHWIL, Switzerland, Aug. 14, 2023 (GLOBE NEWSWIRE)…